ADAR1 Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

ADAR1 Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.63M	Buy	28,604 +3,590	+14%	+$839K	0.35%	64
2026 Q1	$5.72M	Sell	25,014 -300	-1%	-$67.3K	0.34%	67
2025 Q4	$5.4M	Sell	25,314 -11,031	-30%	-$2.28M	0.4%	57
2025 Q3	$7.23M	Buy	36,345 +34,943	+2,492%	+$6.52M	0.68%	39
2025 Q2	$242K	Hold	1,402	–	–	0.04%	150
2025 Q1	$219K	Sell	1,402 -70,000	-98%	-$10M	0.04%	141
2024 Q4	$9.83M	Sell	71,402 -90,000	-56%	-$11.8M	1.96%	12
2024 Q3	$24.1M	Buy	161,402 +110,139	+215%	+$14.9M	3.92%	9
2024 Q2	$6.99M	Buy	51,263 +2,679	+6%	+$365K	1.32%	17
2024 Q1	$7.34M	Buy	48,584 +2,700	+6%	+$385K	1.67%	12
2023 Q4	$5.78M	Buy	+45,884	New	+$4.57M	2.07%	12

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ADAR1 Capital Management's ASND Position: Q2 2026 in Review

ADAR1 Capital Management increased its Ascendis Pharma A/S (ASND) stake by 14% in Q2 2026, buying an estimated $839K and bringing the position to 28,604 shares worth $7.63M. The position accounts for 0.35% of the portfolio, ranked #64.

ADAR1 Capital Management first reported a position in ASND in Q4 2023 and has held it in 11 quarters since. The position peaked at $24.1M in Q3 2024. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

ADAR1 Capital Management held 28,604 shares of Ascendis Pharma A/S worth $7.63M as of Q2 2026.
ADAR1 Capital Management bought 3,590 Ascendis Pharma A/S shares in Q2 2026, an estimated $839K.
Ascendis Pharma A/S made up 0.35% of ADAR1 Capital Management's portfolio in Q2 2026, its #64 holding.
ADAR1 Capital Management first reported a position in Ascendis Pharma A/S in Q4 2023 and has held it in 11 quarters since.
ADAR1 Capital Management's Ascendis Pharma A/S position peaked at $24.1M in Q3 2024.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.